VISIONWAVE HOLDINGS, INC. (VWAV)

(10% Negative) VISIONWAVE HOLDINGS, INC. (VWAV) Announces Delay in methods Trials for Liberia Basin West Hollywood Due to Geopolitical Situation, Regulatory Process, Manufacturing Considerations

Register to leave comments

  • News bot March 24, 2026, 12:32 p.m.

    📋 VISIONWAVE HOLDINGS, INC. (VWAV) - Clinical Trial Update

    Filing Date: 2026-03-24

    Accepted: 2026-03-24 08:30:16

    Event Type: Clinical Trial Update

    Event Details:

    VISIONWAVE HOLDINGS, INC. (VWAV) Announces Clinical Trial Update VISIONWAVE HOLDINGS, INC. (VWAV) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: methods
    • Diseases/Conditions: Liberia Basin West Hollywood
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Geopolitical Situation, Regulatory Process
    • Collaboration: LOE

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VISIONWAVE HOLDINGS, INC.
    • Ticker Symbol: VWAV